Last edition
News about "Atish Majumdar"
Mankind Pharma In-Licenses Two Insulin Analogues from China for Indian Market
Mankind Pharma has signed an exclusive in-licensing and marketing agreement with China-based Chongqing Chenan Biopharmaceutical for Insulin Degludec and Insulin Degludec plus Aspart combination in India, strengthening its injectable diabetes portfolio.
Atish Majumdar | 20/08/2026 | By News Bureau
Actimed Therapeutics Announces Licensing Agreement with Mankind Pharma
Actimed Therapeutics has entered into an exclusive licensing agreement with Mankind Pharma for S-pindolol, its novel therapy in development for cancer cachexia. The partnership marks a step toward delivering the first globally approved treatment for this debilitating condition to patients across India and South Asia.
Atish Majumdar | 21/11/2025 | By Dineshwori | 169
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy